Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2025-11-24 00:00:00 ET · period of report 2025-11-20 · accession 0001966698-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-24 | 2025-11-20 | TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | F - Tax | $17.90 | -19.0K | 355.3K | -5% | -$340.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-11-20 | F | D | 19,024 | $17.90 | 355,282 | D | — | — | (F1) Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |